| 000 | 01145 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517035758.0 | ||
| 264 | 0 | _c20150629 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(15)61087-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aMelanoma research gathers momentum. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 2015 |
||
| 300 |
_a2323 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAustralia _xepidemiology |
| 650 | 0 | 4 | _aBiomedical Research |
| 650 | 0 | 4 | _aCongresses as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aPatient Education as Topic |
| 650 | 0 | 4 | _aRisk Reduction Behavior |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 773 | 0 |
_tLancet (London, England) _gvol. 385 _gno. 9985 _gp. 2323 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(15)61087-X _zAvailable from publisher's website |
| 999 |
_c24995628 _d24995628 |
||